Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
2016 · Journal of Clinical Oncology · 1,145 citations
https://doi.org/10.1200/jco.2016.68.2005
X
Xue Hou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
159
Papers
5.2K
Citations
34
h-index
78
i10-index
Xue Hou is an academic researcher from Minzu University of China. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 34, co-authored 136 publications.
ORCID: 0000-0002-5552-7569Papers by this author
worksEBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
2014 · Oncotarget · 382 citations
https://doi.org/10.18632/oncotarget.2608
Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)
2017 · BMC Cancer · 105 citations
https://doi.org/10.1186/s12885-017-3239-z
RETRACTED ARTICLE: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
2018 · BMC Cancer · 40 citations
https://doi.org/10.1186/s12885-018-4559-3
Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
2012 · Journal of Translational Medicine · 31 citations
https://doi.org/10.1186/1479-5876-10-73
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
2022 · BMC Medicine · 30 citations
https://doi.org/10.1186/s12916-022-02595-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat